Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...
A new human monoclonal antibody moves a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2. SARS-CoV-2, the virus that causes COVID-19 disease, continues to ...
Sanofi has developed a simpler way to create site-specific antibody-to-mannose-6-phosphate (M6P) conjugates that eliminates the need for enzyme remodeling. This more straightforward method makes M6P ...
An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it ...
SAN ANTONIO, May 30, 2024 /PRNewswire/ -- SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at ...
Longevity of neutralizing antibodies is an essential factor for an effective HIV-1 vaccination. An international team has for the first time researched the longevity of neutralizing antibodies in ...